glp-1 drug makers How weight loss drugs are reshaping the food industry The GLP-1 Revolution: From Diabetes

PCLAF-DREAM drives alveolar cell plasticity for lung regeneration

Breaking that medicine into smaller doses would make it hard to measure a consistent dose and increases your risk of infection (from reusing the syringe)

Comparison between laser therapy and non-surgical therapy for periodontitis in rats treated with dexamethasone

The contemporary therapies, while associated with certain limitationsincluding difficulties with access, availability, and costpermit easier dosing, exhibit fewer side effects (especially hypoglycemia), and facilitate weight loss, with ever-increasing evidence of salutary effects across a spectrum of medical disease states (e.g., obstructive sleep apnea, kidney disease, CHF)

Kim JE, Roh E, Lee MH, Yu DH, Kim DJ, Lim TG, et al